A severe human metabolic disease caused by deficiency of the endoplasmatic mannosyltransferase hALG11 leads to congenital disorder of glycosylation-Ip

Rind, Nina and Schmeiser, Verena and Thiel, Christian and Absmanner, Birgit and Luebbehusen, Juergen and Hocks, Julia and Apeshiotis, Neophytos and Wilichowski, Ekkehard and Lehle, Ludwig and Koerner, Christian (2010) A severe human metabolic disease caused by deficiency of the endoplasmatic mannosyltransferase hALG11 leads to congenital disorder of glycosylation-Ip. HUMAN MOLECULAR GENETICS, 19 (8). pp. 1413-1424. ISSN 0964-6906, 1460-2083

Full text not available from this repository. (Request a copy)

Abstract

A new type of congenital disorders of glycosylation, designated CDG-Ip, is caused by the deficiency of GDP-Man: Man(3)GlcNAc(2)-PP-dolichol-alpha 1,2-mannosyltransferase, encoded by the human ortholog of ALG11 from yeast. The patient presented with a multisystemic disorder characterized by muscular hypotonia, seizures, developmental retardation and death at the age of 2 years. The isoelectric focusing pattern of the patient's serum transferrin showed the partial loss of complete N-glycan side chains, which is a characteristic sign for CDG-I. Analysis of dolichol-linked oligosaccharides in patient-derived fibroblasts revealed an accumulation of Man(3)GlcNAc(2)-PP-dolichol and Man(4)GlcNAc(2)-PP-dolichol. Determination of mannosyltransferase activities of early steps of lipid-linked oligosaccharide biosynthesis in fibroblasts indicated that the patient was deficient in elongating Man(3)GlcNAc(2)-PP-dolichol. These findings gave rise to genetic analysis of the hALG11 cDNA, in which homozygosity for mutation c.T257C (p.L86S) was identified. Verification of the mutation as a primary cause for the genetic defect was proved by retroviral expression of human wild-type and mutated ALG11 cDNA in patient-derived fibroblasts as well as using a yeast alg11 deletion strain as a heterologous expression system for hALG11 variants. Immunofluorescence examinations combined with western blotting showed no differences of intracellular localization or expression of ALG11 between control and patient fibroblasts, respectively, indicating no mislocalization or degradation of the mutated transferase.

Item Type: Article
Uncontrolled Keywords: LINKED OLIGOSACCHARIDE BIOSYNTHESIS; SACCHAROMYCES-CEREVISIAE; N-GLYCOSYLATION; CDG-II; ALG11; RETICULUM; YEAST; GENE;
Subjects: 500 Science > 580 Botanical sciences
Divisions: Biology, Preclinical Medicine > Institut für Pflanzenwissenschaften
Depositing User: Dr. Gernot Deinzer
Date Deposited: 03 Aug 2020 07:11
Last Modified: 03 Aug 2020 07:11
URI: https://pred.uni-regensburg.de/id/eprint/24822

Actions (login required)

View Item View Item